The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 0.75 — distress zone — historically elevated failure riskWatch
Where the revenue comes from
Fiscal 2025, as Bausch & Lomb Corp reports it. History and quarterly detail are in the app.
- Vision Care$2.9B
- Pharmaceuticals$1.3B
- Surgical$894.0M
Leadership changes
From Bausch & Lomb Corp's own filings, the day they're filed.
- Eduardo C. Alfonso · directors · departureeff. 2026-01-01
- Steven H. Collis · directors · departureeff. 2026-01-01
- Brett Icahn · directors · departureeff. 2025-08-14
Latest filings
- 8-K · Company announcement2026-05-20
- 8-K · Company announcement2026-04-29
- 10-Q · Quarterly report2026-04-29
- DEF 14A · Annual proxy (pay & governance)2026-04-10
- 8-K · Company announcement2026-02-18
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Bausch & Lomb Corp, every answer cited🔒
- The Intelligence Brief — added when Bausch & Lomb Corp's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.